We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Totally Plc | LSE:TLY | London | Ordinary Share | GB00BYM1JJ00 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -5.71% | 8.25 | 8.00 | 8.50 | 8.75 | 8.25 | 8.75 | 986,973 | 12:41:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Newspaper:pubg, Pubg & Print | 135.7M | 1.78M | 0.0091 | 9.07 | 16.22M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/11/2021 10:55 | What more does the market need to hear. I can see this back above 40p in the next couple of weeks.... | nobbygnome | |
16/11/2021 10:54 | Yes, the updates on acquisitions will be very interesting and probably the main share price driver in the upcoming period for two main reasons. Firstly, they will be earnings enhancing and secondly it will remove the uncertainty that the prospective acquisitions have brought. The key element on acquisitions, other than that they will be earnings enhancing, is that they will be funded from cash and NO cash raise will be required. Sounds like we could get update on this fairly soon. They aren’t going to be acquiring companies that need propping up and some of them will be new areas/opportunities that have come out of the pandemic. | gbcol | |
16/11/2021 10:40 | Interesting we should see an 'exciting' earnings enhancing acquisition very shortly. Excellent time to buy IMHO! | nobbygnome | |
16/11/2021 10:39 | The presentation shows what a magnificent company this is. Undervalued and good to see the price has gone up during the meeting..... | nobbygnome | |
16/11/2021 10:38 | I hope you did sell quazie, it's now lovely and blue and should be for quite a while.The buy and build strategy will pay off big time and they are also paying dividends whilst they do that. Not too many companies like that about imho. | coldspring | |
16/11/2021 10:24 | On investormeetcompany since 10 a.m. Will be worth watching when recording is released. Positive on acquisition negociations - not short of "really interesting" options. Looking for earnings enhancement, not cash guzzlers. "Watch this space". Cost inflation built into NHS contracts. "Always looking at margins & quality. Growing into higher returns. Acruals :£5M trade payables, HMRC £2M, staff also. Very clear & direct answers to investor questions. Positive outlook. Closed. | napoleon 14th | |
16/11/2021 09:35 | TLY have built a diversified business model. The Urgent Care division, with recurring revenues of £100m+++ is their bread and butter. The BoD have done exactly what they said they would - building a leading out of hospital business to cope with the challenges of the NHS. Read the company/sector newsflow: They bought Greenbrook in 2019 because of the changes expected in the 2019 NHS Long term plan. That plan was delayed due to Brexit, GE (Dec 2019) and then covid, all beyond TLY's control. Now, The NHS Long Term Plans are going through Parliament. TLY are prepared for these changes. 2019 - Greenbrook acquisition document: "BACKGROUND TO AND REASONS FOR THE ACQUISITION The Board believes Greenbrook Healthcare to be a strong acquisition candidate, for the following reasons: l Growing market for outsourced urgent care services The Directors believe that publications such as the Integrated Urgent Care Service Specification published in August 2017, which calls for all A&Es to establish adjacent UCCs1, and the NHS Long Term Plan published in January 20192 demonstrate the potential market for services being provided by both Vocare and Greenbrook Healthcare. The Directors also believe that there is increasing demand for urgent care services nationwide and a need to develop innovative delivery models to support the delivery of key NHS national performance targets." "l New services and opportunities The acquisitions completed to date by Totally have offered opportunities for the Group to enhance the portfolio of services it delivers as part of an out-of-hospital healthcare strategy. This strategy is in line with NHS policy and its vision for the delivery of out-of-hospital healthcare services. The Directors believe the acquisition of Greenbrook Healthcare will help enable Totally to deliver further on its strategy to become a leading provider of out-of-hospital healthcare in the UK. In addition, Totallyâ€&trade services, integrated urgent care, physiotherapy, community-based dermatology, referral management services and clinical health coaching provide opportunities to support Greenbrook Healthcare and the urgent care services it can provide and offer to patients. " | sikhthetech | |
16/11/2021 09:02 | I’ve enjoyed a good run and I’m staying | hybrasil | |
16/11/2021 08:13 | The high margin part of the business (THC) is growing rapidly so overall margins will improve. Plus it's a business generating real cash and paying a relatively high dividend. Looks like a exciting growing business to me.....but each to their own! | nobbygnome | |
16/11/2021 08:09 | It's a fair point quazzie and one I've been considering. I'm going to hold, but not increase, until/unless I see increasing ratio of EBITA v revenue | 2vdm | |
15/11/2021 23:23 | Have decided to sell up here. Got in when share price was in the teens and done alright but realise gross margin on turnover is far too low and eps is also too low going forward. Think this all points to the fact that although the company is winning and renewing contracts and growing turnover, it does not have sufficient pricing power and hence profitability | quazie12 | |
15/11/2021 19:08 | Investor Presentation 10am tomorrow | sikhthetech | |
15/11/2021 17:50 | Totally increases dividend by 100% following ‘strong’ 1H21 results | sikhthetech | |
15/11/2021 17:42 | Looking very wobbly here. | owenski | |
15/11/2021 17:41 | Suggest you ask your questions to the board tomorrow, marvel. But hey you sound so like that fella that sold out about 10p here ;) that it might be embarrassing if others thought you were his double :)) | microscope | |
15/11/2021 17:38 | Marvel, "Trade Creditors is an issue because it has not been broken down into its constituent parts." The CFO did provide a break down. Given the investor presentation is tomorrow morning, you can ask for it again. Btw, you don't have a problem with the huge trade payables of £20m v receivables of £9m at Orph. No breakdown etc. Mcap £140m, their Ceo repeatedly misses expectations, over promises, under delivers and lost credibility... The responses from you, marvelman and 1gw in defense of Orph says it all. Why are huge £20m trade payables ok at Orph??? | sikhthetech | |
15/11/2021 17:14 | Insourcing division was setup only 2 yrs ago. The revenue for the period H1-2022 was double compared to the previous 6 months. The division continues to grow strongly "In the first six months of the current financial year, the division doubled revenues against the previous six months. This is currently the smallest division by revenue (£3.1m in the year to March 2021) but is growing strongly reflecting the market opportunity as hospitals seek to reduce patient waiting lists and the strength of its business proposition. A number of new contracts were awarded in the period including a contract to support the reduction in waiting lists across six hospitals for the Saolta Group of Hospitals in the Republic of Ireland. Prospects for H2 are encouraging with the division being included on major national insourcing frameworks for England, Scotland, Wales and the Republic of Ireland, as well as the local contract framework in Northern Ireland." | sikhthetech | |
15/11/2021 17:12 | Trade Creditors is an issue because it has not been broken down into its constituent parts. We cannot see. for example, how much relates to Deferred Revenue which would be interesting as the other side of the entry will be cash and we would be able to understand how much of the cash is free cash rather than in part being a commitment towards the costs of servicing the advance payment. It is clear to me that although some enjoy bandying together to rubbish my very basic questions, they do not have a clue themselves. Longshanks.."if the company has negative net assets - technical or otherwise - it is still something that should be addressed to make performance criteria clearer"...thank you for making that very obvious point...for which you received a tick down I note which is par for the course on here. | marvelman | |
15/11/2021 17:04 | Allenby, company broker notes: | sikhthetech | |
15/11/2021 15:51 | Back to 30p until the next fantastic news i guess....thats only going by history after fantastic news releases. | spacedust | |
15/11/2021 15:50 | GBCol. Exactly. The reasons behind the payables has been clarified several times. I find it hard to believe someone claiming to be an ex-FD doesn't know the basics of payables. 1gw used to claim the balance sheet was 'horrific'. Like marvelman, he was clueless as well. Spacedust, look forward to your questions in tomorrow's investor presentation. | sikhthetech | |
15/11/2021 13:59 | Spacedust, "anyone going to presentation. Pls ask.." Read the TU. The presentation is online. You can ask the questions yourself. Now, TODAY.. " Questions can be submitted pre-event via the Investor Meet Company dashboard or at any time during the live presentation" Feel free to ask whatever you wish. | sikhthetech | |
15/11/2021 13:51 | I can confirm, there is no debt !! I’ll say that again for those struggling to understand. There is NO DEBT !! | footballl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions